Sudden infant death syndrome (SIDS) cases often have abnormalities of the brainstem raphe serotonergic (5-HT) system. We hypothesize that raphe dysfunction contributes to a failure to autoresuscitate from multiple hypoxic events, leading to SIDS. We studied autoresuscitation in two transgenic mouse models in which exocytic neurotransmitter release was impaired via conditional expression of the light chain from tetanus toxin (tox) in raphe neurons expressing serotonergic bacterial artificial chromosome drivers Pet1 or Slc6a4. 
Introduction
Young mammals exposed to hypoxia-induced apnea and bradycardia can recover spontaneously. This process, called autoresuscitation, is initiated by gasps, each associated with increased sympathetic activity, followed by cardiac and respiratory recovery (Stevens, 1965; Adolph, 1969; Guntheroth and Kawabori, 1975; Gershan et al., 1990 Gershan et al., , 1992 Melton et al., 1996; Fewell, 2005) . Gasping presumably reoxygenates the brain to facilitate cardiorespiratory recovery (St-John and Leiter, 2008) , but it alone does not guarantee success in animals (Jacobi et al., 1991; Deshpande et al., 1999; Saiki et al., 2001) or infants (Meny et al., 1994; Poets et al., 1999; Sridhar et al., 2003) .
Gasping is generated by neurons within the pre-Bötzinger complex (Lieske et al., 2000; Paton et al., 2006) whose discharge is influenced by serotonin (5-HT) (Peña and Ramirez, 2002; Harvey et al., 2006) . Gasp initiation may occur without 5-HT, but 5-HT is essential to sustain gasping and restore breathing (Tryba et al., 2006; Toppin et al., 2007; St-John and Leiter, 2008; St-John et al., 2009 ) in autoresuscitation, independent of its effect on gasping. For example, in rodent pups with 80%-90% reduction in medullary 5-HT content (Erickson and Sposato, 2009; Cummings et al., 2011a,b) , gasping is intact yet autoresuscitation is impaired and mortality increased.
Autoresuscitation failure may account for some cases of the sudden infant death syndrome (SIDS) (Guntheroth and Kawabori, 1975; Leiter and Böhm, 2007; . Observations from SIDS infants being monitored indicate that gasping was present but was ineffective in restoring heart rate (HR) and breathing (Meny et al., 1994; Poets et al., 1999; Sridhar et al., 2003; Poets, 2004) . Many SIDS cases demonstrate abnormalities in the medullary 5-HT system , including a 26% decrease in 5-HT (Duncan et al., 2010) , a mild defect compared with published animal models of 5-HT deficiency and anoxic stress (Erickson and Sposato, 2009; Cummings et al., 2011a,b) .
As a potential closer proxy to the moderate degree of brainstem 5-HT dysfunction in SIDS, we used two mouse models in which exocytic neurotransmission was disrupted ) through the action of transgene-expressed light chain from tetanus toxin (tox) (Schiavo et al., 2000) in some, but not all, 5-HT neurons. In one model, triple transgenic Pet1::Flpe, h␤act::cre, RC::PFTox mice ), we estimate here that, at these early time points of P5 and P12, approximately one-third of medullary 5-HT neurons are targeted for tox expression and that there exist some Pet1 ϩ neurons, which lack immunodetectable levels of tryptophan hydroxylase 2 (Tph2) protein. In the second model (double-transgenic Slc6a4::cre, RC::Ptox mice), we estimate approximately three-fourths of medullary 5-HT neurons are targeted, along with a modest fraction of raphe neurons, which lack immunodetectable levels of Tph2. In these two models, we test the hypothesis that raphe abnormalities perinatally and developmentally, even if limited to portions of the raphe population, can impair the ability to autoresuscitate; that successful autoresuscitation requires normal raphe neurotransmission. In these mice and their littermate controls, we measured baseline breathing, oxygen consumption, HR, and indices of breathing and HR variability (HRV), as well as the gasp latency, recovery of HR and breathing frequency, and survival after each of five, 37 Ϯ 4 s exposures to anoxia at P5, P8, and P12.
Materials and Methods

Ethical approval
All experimental protocols were approved by the Institutional Animal Care and Use Committee at Dartmouth College and at Harvard Medical School and were in accordance with the guidelines of the National Institutes of Health for animal care.
Experimental animals "Slc6a4::cre-silenced" pups were generated by crossing mice carrying RC::Ptox ) to mice carrying the Slc6a4::cre transgene (Gong et al., 2007) , whereas "Pet1::Flpe-silenced" pups were generated by crossing mice carrying RC::PFtox ) with mice carrying both the Pet1::Flpe (Jensen et al., 2008) and h␤act::cre (Lewandoski et al., 1997) transgenes. In this paper we refer to these experimental or "silenced" mice as follows: Slc6a4::cre-silenced (Slc6a4::cre, RC::Ptox mice), and Pet1:: Flpe- For experiments involving Slc6a4::cre-silenced mice, pups were obtained from 12 litters and consisted of 32 "silenced" (15 males, 17 females) and 21 control pups (8 males, 13 females). For experiments involving Pet1::Flpe-silenced mice, pups were obtained from 20 litters and consisted of 37 "silenced" (16 males, 21 females) and 26 control pups (15 males, 11 females).
Genotyping
The genotypes of Slc6a4::cre-and Pet1::Flpe-silenced and control pups were determined as previously described by Kim et al. (2009) and Ray et al. (2011) . Briefly, DNA isolated from tail biopsies from P4 pups was subjected to PCR analysis using TaqDNA polymerase (New England BioLabs) and the following primer sequences (Invitrogen) that are complementary to DNA sequences encoding for Cre, Flpe, or tetanus toxin light chain (tox): 5Ј-GGCATGGTGCAAGTTGAATAACC-3Ј (cre forward primer); 5Ј-GGCTAAGTGCCTTCTCTACAC-3Ј (cre reverse primer); 5Ј-GCATCTGGGAGATCACTGAG-3Ј (Flpe forward primer); 5Ј-CCCATTCCA TGCGGGGTATCG-3Ј (Flpe reverse primer); 5Ј-GCCGATCACCATCAACAACTTC-3Ј (tox forward primer); and 5Ј-GCAGAGCTTCACCAGCAACG-3Ј (tox reverse primer). The PCR protocol consisted of an initial denaturation at 94°C for 5 min, followed by 35 cycles, each consisting of 94°C for 1 min, 60°C for 1.5 min, and 72°C for 1 min and a final extension at 72°C for 10 min. The PCR products generated were separated by agarose gel electrophoresis. The cre, Flpe, and tox amplification products separated on the agarose gel as 400, 800, and 200 bp PCR products, respectively. Slc6a4::cre-silenced pups were identified by the presence of both the cre and tox transgenes, whereas Pet1::Flpe-silenced pups were identified by the presence of all three transgenes, cre, Flpe, and tox, and the respective control pups lacked one or more of the transgenes.
Experimental setup
The experimental setup used in this study was similar to that described previously by Cummings et al. (2011a) . Briefly, ventilation was measured using a head-out plethysmograph system consisting of a body chamber and a head chamber. The body chamber (volume ϭ ϳ60 ml; diameter ϭ 3 cm, length ϭ 8.5 cm) was made from a water-jacketed glass cylinder with inlet and outlet ports that were connected to a water bath, allowing for continuous circulation of water around the chamber. The ambient temperature (T A ) of the body chamber and thus the body temperature (T B ) of the mouse pup were controlled by adjusting the temperature of the water circulating around the glass chamber. Both the T A and T B were continuously monitored with a thermistor probe and a fine thermocouple, respectively (Omega Engineering). The head chamber (volume ϭ ϳ3 ml) was made from the bottom of a 50 ml plastic syringe tube (Terumo Medical) with a piece of vinyl glove covering the larger of the two openings. A rubber gasket (Terumo Medical) was used to hold the piece of vinyl glove in place and to secure the head chamber into the anterior end of the body chamber. A small hole was made in the center of the vinyl glove, where the snout of the mouse pup was inserted and the hole was sealed with Impregum F polyether impression material (3M). The head chamber had an outlet port that was connected downstream to a pump (S-3A/I, AEI Technologies), which pulled air through the head chamber at a rate of 140 ml/min. This high flow rate was chosen to prevent accumulation of CO 2 in the head chamber and to ensure rapid delivery of the experimental gas to the animal. The air exiting the head chamber was passed through a Nafion drying tube (PerkinElmer) before being sampled by oxygen (O 2 ) and carbon dioxide (CO 2 ) analyzers (S-3A/I, AEI Technologies, and Capstar-100, CWE, respectively) to monitor oxygen consumption (V O2 ). A pneumotach connected to the open end of the head chamber was attached to a differential pressure transducer (Validyne Engineering) to measure respiratory activity. Experimental gases were delivered to the head chamber via the open end of a 50 ml syringe tube that was connected to the gas cylinder and then placed over the pneumotach. The pneumotach was calibrated by withdrawing and injecting 0.02 ml of air into the head chamber, and the pressure signal associated with injection of this volume was integrated to determine the flow rate. HR was monitored with a telemetric device (CTA-F40, DSI), which consisted of 2 ECG leads that were placed on the surface of the pup's chest and held in place with a vest made from a cohesive flexible bandage (Andover).
Methods
The experimental protocol followed was modified from Cummings et al. (2011a) . Breathing and HR were measured in Slc6a4::cre-and Pet1::Flpe-silenced and control pups at P5, P8, and P12 in room air (RA) and during 5 brief exposures to a gas mixture consisting of 97% N 2 /3% CO 2 (anoxia). Each pup was separated from the litter, and the rectal temperature and body weight immediately recorded. Fur was removed from the area surrounding the snout and the surface of the chest. The pup was then fitted with the ECG telemetric device, and the snout inserted into the head chamber and sealed with the Impregum F polyether impression material. A fine thermocouple was inserted into the rectum for continuous monitoring of T B , and then the pup was placed in the body chamber where it was allowed to acclimatize in RA for ϳ10 min or until the pup was resting quietly and its T B was stabilized at 36 Ϯ 0.5°C. The T A was adjusted to 35-36 Ϯ 0.5°C for P5 and P8 pups and 34 -35 Ϯ 0.5°C for P12 pups to maintain the T B at 36 Ϯ 0.5°C.
After acclimatization, the pup was allowed to breathe RA for 10 min to assess baseline cardiorespiratory parameters, followed by exposure to 5 brief bouts of anoxia separated by Ն5 min of RA, to assess the ability to autoresuscitate. Each anoxic exposure lasted ϳ30 -40 s, and the pup was allowed to breathe RA for 5 min after the breathing frequency returned to normal before the subsequent anoxic exposure. In some instances, Ͼ10 min was required before the next anoxic exposure due to prolongation of the apnea. DataPac 2K2 data acquisition software system (RUN Technologies) was used to record the breathing and HR analog signals.
Histology
To assess cell specificity and coverage of recombinase activity from the Slc6a4::cre and Pet1::Flpe transgenes in medullary 5-HT neurons, we analyzed P5 and P12 double-transgenic Slc6a4::cre; Ai14 (Ai14 strain: B6.Cg-Gt(ROSA)26Sor tm14(CAG-tdTomato)Hze /J; stock #007909) (Soriano, 1999; Madisen et al., 2010) mice for tdTomato (tdT) expression, and double-transgenic Pet1::Flpe; RC::Fe (Brust et al., 2014) mice for GFP expression. Pups were anesthetized with 1.25% Avertin (Sigma-Aldrich), perfused transcardially with ice-cold PBS followed by ice-cold 4% PFA fixative solution, and brains removed and incubated overnight with gentle agitation in 4% PFA at 4°C. Subsequently, brains were incubated in a 30% sucrose solution (sucrose in 1 M PBS) for 2 d at 4°C, then frozen in tissue freezing medium (Triangle Biomedical Sciences) and cryosectioned coronally at 20 m thickness. Brain sections were collected directly onto superfrost-plus microscope slides (VWR International) and stored at Ϫ80°C until processed.
Approximately every fifth brain section was processed for immunofluorescence detection of (1) Tph2, as an identifier of 5-HT neurons; and (2) the respective reporter molecule (tdT or GFP). Sections were incubated for 1 h at room temperature in blocking serum consisting of 5% normal donkey serum in PBS with 0.1% Triton X-100 (PBS-T), followed by a 24 -48 h incubation at 4°C in primary antibody solution consisting of a 1:1000 (lot PL1986170) or 1:500 (lot PL201527) dilution of rabbit anti-Tph2 antibody (NB100-74555 Novus Biologicals). Included in the primary antibody incubation for double-transgenic Pet1::Flpe; RC::Fe tissue was 1:5000 dilution of chicken anti-GFP antibody (ab13970-100, Abcam). tdT expression in double-transgenic Slc6a4::cre; Ai14 tissue was detected via endogenous fluorescence. Following the 24 -48 h incubation in primary antibody solution, sections were incubated in 1:500 dilutions of secondary antibody in PBS-T for 2 h at room temperature: Pet1::Flpe; RC::Fe tissue tissue was incubated in donkey anti-chick Alexa-488 and donkey anti-rabbit Cy3 (Jackson ImmunoResearch Laboratories, 703-545-155 and 711-165-152, respectively); Slc6a4::cre; Ai14 tissue was incubated in donkey anti-rabbit Cy2 (Jackson ImmunoResearch Laboratories 711-225-152). In addition to the secondary antibody, a 5 g/ml solution of DAPI in PBS was added to label cell nuclei. Recombinase negative sibling controls were stained with secondary antibody only, and then DAPI, to establish and assess background fluorescence. Slides were coverslipped and stored in the dark at 4°C until imaged. If tissue was missing or damaged during the staining process, a replacement (nearest adjacent) section was substituted.
To determine an index reflecting the relative number of Tph2 ϩ medullary cells, immunofluorescence-labeled brain sections were imaged using the 25ϫ objective on a Zeiss LSM780 Laser Scanning Confocal Microscope (Carl Zeiss) using ZEN 2012 (ZEN version 2012, Carl Zeiss Imaging Solutions). Confocal stacks of approximately every fifth section throughout the medullary raphe and along the right lateral paragigantocellularis were collected, images imported into FIJI (http://fiji.sc/Fiji), and colocalization of reporter fluorescence (tdT or GFP) and Tph2 immunofluorescence in the X, Y, and Z planes noted. DAPI signal was used to verify and aid in counting individual cells. Example photomicrographs were taken using a Zeiss Axioplan (10ϫ objective) or a Zeiss LSM confocal (25ϫ and 40ϫ objectives); tiled z stacks were processed as maximum intensity projections in ImageJ. Photomicrographs were then background subtracted and had brightness adjusted for clarity. In three brains, each from independent litters, for each experimental group, we counted an average of 23 or 28 sections from the medullary raphe (rostral-most raphe magnus to caudal-most raphe obscurus) and an average of 22 or 26 sections for the lateral paragigantocellularis, for P5 and P12 tissue, respectively. Tph2-immunopositive neurons were counted and summed to yield a serotonergic neuron index. To determine the percentage of these medullary Tph2-immunopositive neurons that also had a history of recombinase activity and thus reporter or Tox expression, we tallied the colabeled neurons (reporter ϩ and Tph2 ϩ ) and divided by the total number of Tph2 ϩ neurons. Data are presented as mean Ϯ SD. The effects of age and genotype on Tph2 ϩ cell number index and on the percentage of Tph2 ϩ cells also reporter positive were assessed by a two-way ANOVA using age and genotype as factors.
Data analysis
Mortality. The analysis of mortality resulting from anoxic exposures had two components. First, we examined cumulative survival in two initial cohorts. For Slc6a4::cre-silenced mice, an initial cohort of 26 "silenced" and 17 controls was studied at P5, P8, and P12; for Pet1::Flpe-silenced mice, in initial cohort of 19 "silenced" and 20 controls was studied at P5, P8, and P12. Cumulative survival of these cohorts is shown in Figure  2C -E. Second, to allow analysis of age dependence of survival we replaced pups that died at P5 or P8. At P12, the Slc6a4::cre-silenced "mixed" group included 12 pups previously exposed to hypoxia plus 2 pups exposed for the first time. The "mixed" control group included 18 pups previously exposed to hypoxia plus 1 pup exposed for the first time. At P12, the Pet1::Flpe-silenced "mixed" group included 4 pups previously exposed to hypoxia plus 9 pups exposed for the first time. The "mixed" control group included 16 pups that had been previously exposed to hypoxia and 2 being exposed for the first time.
Baseline breathing and HR. LabChart6 (AD Instruments), a digital strip chart recorder that also facilitates data calculations, was used to complete analysis of the data. The last minute of the breathing and HR tracings in RA before the first anoxic exposure was used to assess baseline
, and HR. We also normalized V E and HR to V O2 . V E was calculated as the product of the breathing frequency ( f; breaths min Ϫ1 ) and the tidal volume (V T ; ml g Ϫ1 ). The f was obtained directly from the breathing tracings, whereas integration of the pressure changes associated with respiratory activity was used to calculate the V T . V O2 was calculated as the product of the gas flow rate and the difference between the inspired and mixed expired O 2 normalized to body weight ([Flow (ml/min) ϫ (F IO2 Ϫ F EO2 )]/body weight (g)). HR was calculated directly from the ECG tracings.
Autoresuscitation. After each anoxic exposure, we measured the gasp latency (time to initiate gasping from the onset of primary apnea), the time to recover HR, and breathing frequency, to 90% of baseline.
Breathing and HRV. Three 1 min segments of continuous, nonoverlapping breathing and ECG tracings during the initial RA recordings were used to assess baseline variability in the interbreath intervals (IBIs; s Ϫ1 ) and the R-wave-to-R-wave intervals (RRI; s Ϫ1 ) in both the time and frequency domains. Custom-designed analysis software was used to assess linear and nonlinear measures of breathing and HRV. The SD, root of the mean square of successive differences (RMSSD) and an estimate of the area of the Poincaré first return plot (major axis, L ϫ minor axis, T; L ϫ T) was computed and used to evaluate the nature of interbeat and interbreath variability in the time domain (Carrasco et al., 2001) . HRV in the frequency domain was estimated using the Lomb spectral analysis technique as proposed by Moody (1993) to avoid the spectral distortion caused by resampling of the original RRI time series. Spectral power between limits proposed by Just et al. (2000) were applied to the RRI power spectral density to estimate the low-frequency (LF) band power (0.15-1.5 Hz) and high-frequency (HF) band power (1.5-5.0 Hz). The HF band is thought to reflect parasympathetic inputs to HR control, whereas the LF band is thought to reflect a combination of sympathetic and parasympathetic inputs to HR control (Chatow et al., 1995) .
Statistical analysis
The data are presented as the mean Ϯ SD. The effects of gender and genotype on body weight (BW), body temperature, and baseline breathing and HR parameters were assessed by a two-way ANOVA at each age. When no gender differences were present, the data for both genders were combined and Student's t test comparisons between genotypes were made at each age. Kaplan-Meier survival analyses were used to compare cumulative survival within each genotype compared with control for that genotype and survival at each age. To compare survival between the two experimental genotypes we applied a model with 2 factors: (1) experimental genotype (Pet1::Flpe-silenced vs Slc6a4::cre-silenced) and (2) tox expression (all "silenced," combining both experimental groups vs "nonsilenced control") and used Cox proportional hazard model to examine the effects of specific experimental genotype, tox expression in general, and their interaction, on survival. We also applied a Mantel-Cox log rank test with appropriate adjustment for multiple comparisons. The effects of gender and experimental genotype on the autoresuscitation parameters were assessed by a two-way ANOVA at each age. When no gender differences were present, the data for both genders were combined and reanalyzed by a one-way ANOVA at each age. Bonferroni post hoc comparisons were performed when significant effects were found. The effects of age and genotype on the indices of breathing and HRV were assessed by a two-way ANOVA followed by Bonferroni post hoc comparisons when significant interactions were found.
Results
By P5 and P12, subsets, but not all medullary serotonergic neurons, are cumulatively captured by recombinase drivers To express tox, and thus suppress vesicular neurotransmission in 5-HT neurons, two different recombinase drivers, and thus two different engineered mouse models were used: Pet1::Flpe (Jensen et al., 2008) as the driver in the first mouse model and Slc6a4::cre (Gong et al., 2007) as the driver in the second. Both drivers use bacterial artificial chromosome (BAC) transgenics (Pet1 and Slc6a4 BACs, respectively) in which the transgene product (Flpe or Cre) is capable of recombining FRT-or loxP-containing transgenes, respectively, in 5-HT neurons. To estimate the fraction of tox-manipulated 5-HT neurons achieved by these recombinase drivers by the ages of P5 and P12 (as opposed to in the adult) (Gong et al., 2007; Jensen et al., 2008; , we estimated the fraction of reporter-labeled 5-HT neurons (as a proxy for tox) in double-transgenic Pet1:: Flpe; RC::Fe mice (RC::Fe is a ROSA26/CAG knock-in allele harboring a Flpe-dependent eGFP reporter) and double-transgenic Slc6a4::cre; Ai14 (B6.Cg-Gt(ROSA) 26Sor tm14(CAG-tdTomato)Hze ) mice (the latter transgene is a ROSA26/ CAG knock-in allele harboring a Cre-dependent red fluorescent tdT reporter) (Madisen et al., 2010) (Fig. 1) . First, we determined an index reflective of the relative number of medullary serotonergic neurons in the P5 and P12 brainstem based on Tph2 immunopositivity; Tph2 is the rate-limiting enzyme in serotonin synthesis and thus one marker of serotonergic neuron identity. Cell counts were indistinguishable between genetic models, indicating neutrality of drivers and reporters with respect to serotonergic neuron populations, as would be expected by these neutral recombinase and reporter transgenes (Fig. 1N ). For each model, three brains, each from independent litters, were analyzed. We then calculated for each model the percentage of Tph2-immunopositive neurons that were also reporter-positive, and thus captured by each driver. From this, we extrapolated an estimation of serotonergic neurons likely captured for tox expression and consequent neuronal silencing when these same drivers were used to recombine RC::PFtox or its derivative RC::Ptox , both knock-in alleles of the R26 locus and thus likely similarly susceptible to recombination as the employed R26 reporter alleles. We found that ϳ35% (or onethird) of the medullary Tph2-immunopositive neurons expressed GFP in Pet1::Flpe; RC::Fe mice at P5 and P12 (Fig. 1O) , with the greatest medullary colabeling observed in the rostral medulla in the area of the raphe magnus. As previously observed for Pet1 BAC drivers (Pelosi et al., 2014), we also observed that not all GFPmarked neurons expressed detectable levels of Tph2, suggesting that there exist a subset of raphe neurons that express the serotonergic transcription factor gene Pet1 but express low levels or no Tph2 at these time points. Grossly, this Pet1 ϩ , Tph2 negative or low subpopulation appeared comparable in magnitude to the double-positive cells within the medullary raphe, but varied along the rostrocaudal extent of the raphe. In all cases, GFP-marked cells were restricted to the brainstem raphe system and not found elsewhere in the brain. In the dorsal raphe system of this Pet1::Flpe model (Fig. 1D) , the percentage Tph2 ϩ cells captured was much greater, although not quantified here because of the substantive technical challenges around cell number and density. By contrast, in double-transgenic Slc6a4::cre; Ai14 mice (Fig. 1O) , ϳ73% (or three-fourths) of the medullary Tph2-immunopositive neurons expressed reporter, in this case tdTomato, thus capturing a majority portion of the 5-HT neuron population both at P5 and P12. Here too, not all tdTomato-marked raphe neurons expressed immunodetectable levels of Tph2, albeit at a lower frequency than in the 
Tph2
negative or low raphe cells. Of note, Slc6a4::cre; Ai14 mice too showed reporter expression in nonserotonergic cells outside the raphe system, including the thalamus, cerebral cortex, and cerebellum. Within the medullary raphe, though, very few reporter-positive, Tph2 negative or low neurons were observed. In the medulla, these two drivers (Pet1::Flpe and Slc6a4::cre) overlapped in neurons captured most substantially in the raphe magnus. 
Baseline physiological characteristics
Slc6a4::cre-silenced pups were significantly smaller than control pups at all ages by 11%-23% (P5: p ϭ 0.028, P8: p ϭ 0.0001, P12: p ϭ 0.001). They had significantly slower breathing than controls at all ages by 9%-16% (P5: p ϭ 0.023, P8: p ϭ 0.0001, P12: p ϭ 0.024), but their V T was significantly larger at P8 and P12 by 18%-21% (P5: p ϭ 0.134, P8: p ϭ 0.0001, P12: p ϭ 0.009). There was no significant difference in V E (P5: p ϭ 0.463, P8: p ϭ 0.821, P12: p ϭ 0.665) or V O2 (P5: p ϭ 0.314, P8: p ϭ 0.243, P12: p ϭ 0.661) at any age. HR was slightly (46 bpm) but significantly slower than control pups only at P8 (P5: p ϭ 0.158, P8: p ϭ 0.0002, P12: p ϭ 0.763) ( Table 1) .
Pet1::Flpe-silenced pups were also significantly smaller than control pups at P5 and P8 by 15%-21% (P5: p ϭ 0.011, P8: p Ͻ 0.0001, P12: p ϭ 0.092). They too had significantly slower breathing than control pups at P5 and P8 by 14% (P5: p ϭ 0.024, P8: p ϭ 0.0008, P12: p ϭ 0.374), and their V T was significantly larger at P8 and P12 by 18%-34% (P5: p ϭ 0.109, P8: p ϭ 0.0008, P12: p ϭ 0.0002), which in this case resulted in a 28% larger V E at P12 (P5: p ϭ 0.573, P8: p ϭ 0.621, P12: p ϭ 0.001). V O2 was slightly but significantly lower at P5 and higher at P12 (P5: p ϭ 0.018, P8: p ϭ 0.988, P12: p ϭ 0.049). HR was significantly slower at P5 and P8 by 6%-10% (P5: p Ͻ 0.0001, P8: p ϭ 0.015, P12: p ϭ 0.684). There were no gender differences in baseline characteristics in either of the two mouse models. These changes in body weight, f, and V T are similar to findings in other, more severe models of 5-HT dysfunction (Erickson and Sposato, 2009; Cummings et al., 2011a,b) .
Failed autoresuscitation in Slc6a4::cre-silenced and Pet1::Flpe-silenced pups at a critical age Results from study of the initial cohort subjected to repeated anoxia at P5, P8, and P12 In both Slc6a4::cre-silenced and Pet1::Flpe-silenced pups, autoresuscitation was less effective compared with controls following repeated episodic exposure to anoxia and resulted in increased mortality compared with control pups at P5 and P8. Typical examples of HR and breathing responses during successful and failed autoresuscitation are shown in Figure 2 , A and B, respectively. In general, successful autoresuscitation was characterized by a brief primary apnea and rapid recovery of normal HR and eupneic breathing following the onset of gasping ( Fig. 2A) , whereas failed autoresuscitation was characterized by a prolonged primary apnea (delayed gasping) and an inability to recover HR and eupneic breathing despite vigorous gasping (Fig. 2B) .
Of the 26 Slc6a4::cre-silenced pups tested initially at P5, only 42% (11 of 26) survived to the endpoint of the study at P12 (cumulative survival), compared with 94% (16 of 17) survival among the control pups ( Fig. 2C ; p ϭ 0.001). All deaths occurred during the anoxic challenge at P5-P6 or P8-P9, except for one control and one "silenced" pup that died of unknown causes in their home cages between test days.
Similarly, of the 19 Pet1::Flpe-silenced pups tested initially at P5, only 16% (3 of 19) survived to the endpoint of the study at P12 (cumulative survival), compared with 75% (15 of 20) survival among the control pups ( Fig. 2D ; p ϭ 0.001). All deaths occurred during the anoxic challenge on experimental days P5-P6 and P8, except for one "silenced" and three control pups that died of unknown causes in their home cages between test days.
We compared the cumulative survival between Slc6a4:: cre-silenced and Pet1::Flpe-silenced pups (shown in Fig. 2 ) by applying Cox proportional hazard model to examine the effects of experimental genotype (Pet1::Flpe-silenced vs Slc6a4:: cre-silenced), tox expression (all silenced, expressing tox, vs all control, not expressing tox), and their interaction on survival time. We apply statistically the word "genotype" to refer to (1) Slc6a4::cre-silenced and (2) Pet1::Flpe-silenced (i.e., each of these two groups is a separate genotype). As there can be tox expression in both of these genotypes, we also apply statistically whether or not there is tox expression as a parameter to be analyzed. The test was designed to ask whether there is a significant difference in survival between Slc6a4::cre-silenced and Pet1::Flpe-silenced pups (i.e., between the two genotypes). This distinction is necessary as one initial hypothesis was that Slc6a4::cre-silenced might differ from Pet1::Flpe-silenced in survival given the different fraction of manipulated serotonergic cells.
The main effects of both genotype (Slc6a4::cre-silenced vs Pet1::Flpe-silenced) and tox expression (all silenced vs all control) were significant ( p ϭ 0.0460 and p ϭ 0.0002; respectively), but the interaction between them was not ( p ϭ 0.5431). We also applied a Mantel-Cox log rank test with appropriate adjustment for multiple comparisons. Survival differences between each control and experimental genotype were highly significant ( p Ͻ 0.0001); survival differences between the two models of toxexpressing mice were not significant ( p ϭ 0. 3299). There was no Vol., Respiratory volume here expressed simply as the raw tracing in mV/s as for the purposes of this study quantification is not required. C, D, Kaplan-Meier cumulative survival analysis for initial cohorts of (C) Slc6a4::cre-silenced (n ϭ 26) and control (n ϭ 17) pups and (D) Pet1::Flpe-silenced (n ϭ 19) and control (n ϭ 20) pups during the anoxic challenge at P5, P8, and P12 (for statistics, see text). E, Combined survival results of both Slc6a4::cre-silenced and Pet1::Flpe-silenced and controls in the initial cohort. At both P5 and P8, there is significantly less survival in silenced pups. *p ϭ 0.01 (ANOVA at each age, with survival and genotype, silenced vs nonsilenced, as factors). At P12, there was no effect on survival of 5-HT neuron silencing.
significant difference in survival time between control pups and tox-expressing pups that depended on experimental genotype (i.e., the difference in survival between tox-expressing and non-tox-expressing pups was statistically the same between Slc6a4::cre-and Pet1::Flpe-silenced pups). There were no gender differences in the number of Slc6a4::cre-or Pet1::Flpe-silenced and control pups that failed to autoresuscitate at any age. Given that there was no significant difference in survival between the two experimental groups (Pet1::Flpe and Slc6a4::cre silenced), we combined the results at the different ages to emphasize the age dependence of survival (Fig. 2E) . Although overall at both P5 and P8 there is significantly less survival in silenced pups, by P12 there was no effect on survival of 5-HT neuron silencing within the cohort of pups shown in Figure 2 .
Results from study of repeated anoxia at P5, P8, and P12, including pups added to replace those that succumbed (data not shown) To further examine whether there was an age dependence in the ability to survive repeated bouts of anoxia, we added pups after P5 to replace pups that died. There remains no effect of repeated anoxia on survival at P12 (data not shown). At P12, the Slc6a4::cre-silenced group included 12 pups previously exposed to anoxia plus 2 pups exposed for the first time; the controls included 18 pups previously exposed to anoxia plus 1 pup exposed for the first time. The Pet1::Flpe-silenced group included 4 pups previously exposed to anoxia plus 9 pups exposed for the first time; the controls included 16 pups that had been previously exposed to anoxia and 2 being exposed for the first time. Thus, the high survival of silenced pups at P12 was not clearly related to the presence or absence of prior anoxic exposure.
Gasping, HR, and eupnea recovery in autoresuscitation
Slc6a4::cre-silenced pups that went on to die at P5 showed abnormal responses to the anoxic challenges in the assay compared with sibling control pups: they took ϳ3 times longer to initiate gasping ( Fig. 3A ; p ϭ 0.0001), ϳ5 times longer to recover HR to 90% of baseline ( Fig. 3A ; p ϭ 0.0001), and ϳ2 times longer to recover eupneic breathing to 90% of baseline ( Fig. 3A ; p ϭ 0.011). Compared with Slc6a4::cre-silenced pups that survived, Slc6a4::cre-silenced pups that went on to die at P5 took ϳ2 times as long to initiate gasping ( p ϭ 0.0002) and ϳ2 times as long to recover normal HR to 90% of baseline ( p ϭ 0.0009). Compared with controls, Slc6a4::cre-silenced pups that survived had an ϳ2-fold longer time to initiate gasping ( Fig. 3A ; p ϭ 0.0005), but recovery times of HR and eupnea were unaffected.
Similarly, Pet1::Flpe-silenced pups that ultimately died at P5 compared with controls took ϳ4 times longer to initiate gasping ( Fig. 3B ; p ϭ 0.0001) and ϳ4 times longer to recover HR and eupneic breathing to 90% of baseline ( Fig. 3B ; p ϭ 0.0004 and p ϭ 0.0002, respectively). Compared with Pet1::Flpe-silenced pups that survived, Pet1::Flpe-silenced pups that died also took ϳ4 times longer to initiate gasping ( p ϭ 0.0001) and to recover eupneic breathing ( p ϭ 0.0056). The times to initiate gasping and to recover HR and eupneic breathing to 90% of baseline in Pet1::Flpe-silenced pups that survived were not significantly different from controls that survived.
Inspection of Figure 3 suggests that, in both the Slc6a4::creand Pet1::Flpe-silenced and control pups, the times to recover normal HR and eupneic breathing were directly associated with the gasp latency. Linear regression analysis using the individual data points summarized in Figure 3 shows that, in Slc6a4::cre-silenced pups: HR and eupneic recovery times versus gasp latency are significantly related ( p ϭ 0.001, R 2 ϭ 0.68 and p ϭ 0.001, R 2 ϭ 0.3, respectively); and in Pet1::Flpe-silenced mice: HR and eupneic recovery times versus gasp latency are significantly related ( p ϭ 0.001, R 2 ϭ 0.68; p ϭ 0.001, R 2 ϭ 0.63, respectively).
Can variability of baseline breathing and HR in Slc6a4::creand Pet1::Flpe-silenced pups predict autoresuscitation failure? We evaluated whether variability of HR or breathing measured at P5 would predict subsequent mortality. With respect to HRV measured as SD, RMSSD, major axis of Poincare first return plot (L) ϫ minor axis of Poincare first return plot (T), LF, or HF of the RR interval, there was no significant effect of genotype at P5 in either Slc6a4::cre-silenced or Pet1::Flpe-silenced pups compared with control pups, nor was there a significant effect of gender (data not shown).
Breathing variability measured at P5 as SD, RMSSD, and L ϫ T of the IBI differed by genotype (Fig. 4) . At P5, there was a significant effect of genotype in Pet1::Flpe-silenced pups with a greater SD ( p ϭ 0.041) and RMSSD ( p ϭ 0.025) and in Slc6a4::cre silenced pups with a greater SD ( p ϭ 0.00982), LxT ( p ϭ 0.0051), and RMSSD ( p ϭ 0.00666). There was no effect of gender. To test for whether the significant genotype effect could predict mortality, we applied the Bonferroni post hoc test comparing silenced pups that died, or survived, to controls. At P5 in Slc6a4::cre-silenced pups compared with controls, the SD and the RMSSD of the IBI were greater in those that died ( p ϭ 0.0099 and p ϭ 0.0073, respectively) and in those that survived ( p ϭ 0.0147 and p ϭ 0.0071, respectively). L ϫ T was greater only in silenced pups that died ( p ϭ 0.0026). At P5 in Figure 3 . Prolonged gasp latency and delayed recovery of HR and eupnea following anoxic exposure among Slc6a4::cre-and Pet1::Flpe-silenced pups at postnatal (P) day 5. A, Slc6a4::cre pups at P5: n ϭ 17 for control pups (Crt); n ϭ 21 for "silenced" pups that survived (SS); n ϭ 5 for "silenced" pups that died (SD). B, Pet1::Flpe pups at P5: n ϭ 19 for control pups (Crt); n ϭ 8 for "silenced" pups that survived (SS); n ϭ 11 for "silenced" pups that died (SD). *p ϭ 0.01, significant differences from controls that survived. **p ϭ 0.001, significant differences from controls that survived. ***p ϭ 0.0001, significant differences from controls that survived.
† p ϭ 0.01, significant differences from "silenced" pups that survived. † † p ϭ 0.001, significant differences from "silenced" pups that survived.
† † † p ϭ 0.0001, significant differences from "silenced" pups that survived. The data are presented as the mean Ϯ SD. One-way ANOVA at each age, with genotype as the between-subjects factor; Bonferroni post hoc comparisons.
Pet1::Flpe-silenced mice, the SD and the RMSSD of the IBI were greater in silenced pups that died than controls ( p ϭ 0.0125 and p ϭ 0.0073, respectively).
Discussion
Strategy
We hypothesized that brainstem abnormalities targeted to portions of the medullary 5-HT neuron population could impair the ability to autoresuscitate in early postnatal life (i.e., that normal serotonergic neurotransmission is essential to this vital process). We used Pet1::Flpe (Jensen et al., 2008) and Slc6a4::cre (Gong et al., 2007) driver lines coupled with the respective conditional tox (tetanus toxin light chain)-encoding R26 knock-in alleles ) to selectively impair exocytic neurotransmitter release during development and then examined postnatally (P5, P8, and P12) the response to repeated anoxic stress such as to induce autoresuscitation.
Main findings
Significant findings include the following: (1) "Silencing" of portions of raphe neurons in triple transgenic Pet1::Flpe, h␤actin::cre, RC::PFtox pups or double-transgenic Slc6a4::cre, RC::Ptox pups resulted in autoresuscitation failure at P5 and P8 but not P12. (2) There was no significant difference between the two experimental genotypes in this reduced ability to survive repeated anoxic stress. (3) In "silenced" pups of both experimental genotypes that died at P5, gasp latency was increased as were the times for recovery of HR and eupneic breathing, which were significantly correlated with the gasp latency. (4) In both experimental genotypes, analysis of baseline breathing variability at P5 could distinguish between "silenced" and control pups, but not predict future mortality. (5) In both experimental genotypes compared with controls, the pups were smaller and had slower HRs, slower breathing frequency, and larger tidal volumes, with variable effects on V E and V O2 . (6) In both models, there appear to be some driver-captured cells within the brainstem in which Tph2 expression is low or absent at P5 and P12, albeit more substantial in the Pet1::Flpe model. (7) Manipulated neurons shared between both experimental models were predominantly restricted to raphe serotonergic neurons.
Failed and delayed autoresuscitation in Slc6a4::cre-and Pet1::Flpe-silenced pups at a critical age The drivers used to switch on tox expression in 5-HT neurons captured a portion of but not all medullary Tph2-immunopositive neurons at P5 and P12, approximately one-third of medullary 5-HT neurons using Pet1:;Flpe; and approximately three-fourths using Slc6a4::cre, with the greatest overlap in manipulated cell populations in the dorsal raphe and the medullary region of the raphe magnus. These animal models, compared with others exhibiting greater serotonergic neuron deficiencies such as the 5,7-DHT-treated rat pups and the Lmx1b and Pet1-null mice (Hodges et al., 2009; Cummings et al., 2011a,b) , may offer new pathophysiological insights into SIDS in which infants demonstrate a seemingly modest ϳ26% deficiency in medullary 5-HT as measured from postmortem tissue punches (Duncan et al., 2010) .
In both genetic models, the drivers captured some raphe neurons lacking in immunodetectable Tph2. In the case of the Pet1::Flpe driver, the affected neurons appear to be bona fide Pet1 expressors, suggesting the existence of a novel Pet1 ϩ , Tph2 low or negative neuron subset. These findings are consistent with our recent transcriptomic studies (Okaty et al., 2015) that uncovered a population of neurons defined as Pet1 ϩ , Tph2 low , Slc6a4 low ; moreover, Pelosi et al. (2014) report a subset of Pet1 ϩ raphe neurons lacking detectable levels of Tph2. While the silencing of these Tph2 low or negative raphe neurons may contribute to the observed autoresuscitation defects, the simplest model points to the overlapping neuron subset captured by each of our two drivers given the similarity in defects across both models. This shared population is largely Tph2 ϩ (given that the bulk of the Slc6a4::cre-captured cells are Tph2 ϩ ) and resident within the ra- phe. Further work will be required to understand the significance of these Pet1 ϩ , Tph2 low neurons, and the developmental time patterns of features generally used to identify 5-HT neurons.
Dramatic phenotypes were observed in these mouse models, despite manipulating only a portion of the raphe neuron population. Mortality was increased significantly, and autoresuscitation prolonged during repeated exposure to anoxia at a critical period in postnatal development. The first week of postnatal development in rodents is a time of significant change in central neural pathways controlling cardiorespiratory function (WongRiley and Liu, 2005; Fong, 2010) . From our results, P5-P8 appears to be a critical period in which a decrease in raphe neurotransmission can increase vulnerability during autoresuscitation from repeated exposure to anoxia. At P12, there was no difference in survival compared with controls. Our study did include added pups at P8 and P12 that consequently had fewer cumulative anoxic exposures, but the improved survival included both pups that had prior anoxic exposure and pups that did not.
The increased mortality in the pups with tox-perturbed neurons at P5 and P8 agrees with previous reports that repeated exposure to anoxia increases mortality in Pet1-null mouse pups at P8 but not P12 (Cummings et al., 2011a) and in 5,7-DHT-treated rat pups at P7-P10 (Cummings et al., 2011b) . In these earlier studies, the serotonin deficiency in the medulla is more substantial. The critical period of increased vulnerability in the Pet1-null pups (P8) is similar to the critical period (P5-P8) in this study. In the 5,7-DHT-treated rat pups, more anoxic exposures (15) were required before autoresuscitation failed. Rats appear to be more tolerant of hypoxia than mice (Fong, 2010) , which may reflect temporal differences in postnatal brain development between mouse and rat (Schneider and Norton, 1979) . We suggest that even a moderate deficiency in raphe neuron function may substantially reduce the ability to autoresuscitate from anoxiainduced apnea in early postnatal life.
In both Pet1::Flpe-and Slc6a4::cre-silenced pups that eventually succumbed to anoxia, gasping was significantly delayed compared with surviving control pups. This finding is consistent with previous reports in other 5-HT-deficient animal models exposed to a single (Erickson and Sposato, 2009) or multiple bouts of anoxia (Cummings et al., 2011a,b) . In previous studies and this study, gasping appeared normal once it began, which is in agreement with in situ studies in juvenile rats and mice that showed that 5-HT is not critical for gasp generation (Toppin et al., 2007; St-John and Leiter, 2008; St-John et al., 2009) . Our results, however, suggest that 5-HT and/or raphe neuron function is critical for the timely initiation of gasping (Chen et al., 2013) . Erickson and Sposato (2009) suggest that this prolonged gasp latency might reflect an altered hypoxic threshold for activation of gasping (Guntheroth and Kawabori, 1975; Lawson and Thach, 1977) in the pre-Bötzinger complex (Lieske et al., 2000; Paton et al., 2006) , which contains hypoxic-sensitive neurons (Solomon, 2000; Neubauer and Sunderram, 2004) . Serotonin is known to modulate the activity of pre-Bötzinger complex neurons (Hodges and Richerson, 2008; Ptak et al., 2009 ) and may enhance sensitivity of hypoxia-sensitive neurons within the pre-Bötzinger complex. When this excitatory stimulation from 5-HT is reduced, as is likely in the "silenced" pups in this study, more severe hypoxia might be required to activate these neurons and initiate gasping.
Pet1::Flpe-and Slc6a4::cre-silenced pups, in addition to a prolonged gasp latency, took longer to recover normal HR and breathing frequency after the initiation of gasping than control pups that survived, similar to previously reported studies in neonatal 5-HT-deficient rodents (Erickson and Sposato, 2009; Cummings et al., 2011a,b) . Cardiac resuscitation follows reoxygenation of the heart as a result of gasping, which in turn leads to respiratory resuscitation and resumption of normal body functions (Gershan et al., 1992) . A delay in cardiac reoxygenation due to a delay in the initiation of gasping could account for the delay in the recovery of HR and eupneic breathing and by extension, contribute to autoresuscitation failure. In BALB/c mice, when oxygen availability is delayed, autoresuscitation fails, suggesting that early gasps may be more effective in reoxygenating the heart and promoting successful autoresuscitation than later gasps (Gershan et al., 1990) . In support of this conclusion, we found that the time to recover normal HR and breathing frequency was directly related to the gasp latency.
Altered baseline breathing and HRV in Slc6a4::cre-and Pet1::Flpe-silenced pups We found that the variability of baseline breathing, but not HR, was consistently greater in "silenced" pups of both animal models compared with controls. The ability to identify groups at greater risk of autoresuscitation failure (i.e., are more vulnerable) is a significant finding that might be applicable to human infants.
In conclusion, we found that perturbations affecting even a modest portion of raphe neurons, including 5-HT neurons, can compromise autoresuscitation postnatally. Raphe neurons appear to act during early development to protect against lethal consequences of repeated exposure to anoxia, and P5-P8 is a critical period of increased vulnerability. The gasp latency is important in determining the speed and/or success of autoresuscitation and the timely initiation of gasping may be dependent on normal serotonergic signaling. Baseline measures of breathing variability identified the groups of animals at greater risk and may, therefore, be useful in identifying infants at an increased risk for SIDS. We conclude that the serotonergic deficiency, reflected as a decrease in tissue levels of 5-HT that has been documented in SIDS cases (Duncan et al., 2010) , may alter respiratory and autonomic responses to severe hypoxia in early postnatal life and may potentially be causally related to the SIDS pathogenesis.
